ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.

Published

Journal Article

Diagnosis and management of prostate cancer post treatment is a large and complex problem, and care of these patients requires multidisciplinary involvement of imaging, medical, and surgical specialties. Imaging capabilities for evaluation of men with recurrent prostate cancer are rapidly evolving, particularly with PET and MRI. At the same time, treatment options and capabilities are expanding and improving. These recommendations separate patients into three broad categories: (1) patients status post-radical prostatectomy, (2) clinical concern for residual or recurrent disease after nonsurgical local and pelvic treatments, and (3) metastatic prostate. This article is a review of the current literature regarding imaging in these settings and the resulting recommendations for imaging. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

Full Text

Duke Authors

Cited Authors

  • Expert Panel on Urologic Imaging:, ; Froemming, AT; Verma, S; Eberhardt, SC; Oto, A; Alexander, LF; Allen, BC; Coakley, FV; Davis, BJ; Fulgham, PF; Hosseinzadeh, K; Porter, C; Sahni, VA; Schuster, DM; Showalter, TN; Venkatesan, AM; Wang, CL; Remer, EM

Published Date

  • May 2018

Published In

Volume / Issue

  • 15 / 5S

Start / End Page

  • S132 - S149

PubMed ID

  • 29724417

Pubmed Central ID

  • 29724417

Electronic International Standard Serial Number (EISSN)

  • 1558-349X

Digital Object Identifier (DOI)

  • 10.1016/j.jacr.2018.03.019

Language

  • eng

Conference Location

  • United States